Natriumchlorid Fresenius Kabi (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchlorid Fresenius Kabi, is an electrolyte solution presented as an intravenous solution for intravenous use. It restores extracellular sodium and chloride balance in patients who need fluid and electrolyte replacement, such as during surgery, trauma, or dehydration. GNH USA supplies Natriumchlorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchlorid Fresenius Kabi is used in clinical situations that require restoration of sodium and chloride balance through the intravenous route. - Hyponatremia: corrects low serum sodium levels and supports normal cellular function. - Hypochloremia: replenishes chloride to maintain acid‑base equilibrium. - Fluid resuscitation: provides isotonic volume for patients with hypovolemia due to bleeding or dehydration. - Diluent for IV medications: serves as a compatible carrier for many injectable drugs.

Sodium chloride IV solution may cause adverse reactions, most of which are related to electrolyte shifts or infusion technique.

Common Side Effects: - Hypernatremia: elevated serum sodium leading to thirst and neurologic symptoms. - Hyperchloremia: increased chloride that can affect acid‑base status. - Fluid overload: signs of edema or pulmonary congestion. - Phlebitis: inflammation at the infusion site. - Local irritation: pain or redness at the catheter entry.

Serious or Rare Side Effects: - Cardiac arrhythmia: caused by severe electrolyte imbalance. - Pulmonary edema: acute respiratory distress from excess fluid. - Anaphylactoid reaction: rare hypersensitivity to the solution components. - Metabolic acidosis: from excessive chloride load. - Electrolyte‑induced seizures: in extreme sodium disturbances.

When using Natriumchlorid Fresenius Kabi, clinicians should observe several safety measures. - Assess baseline electrolytes: verify serum Na⁺ and Cl⁻ before infusion. - Monitor fluid balance: track input, output, and weight changes. - Adjust infusion rate in renal impairment: slower rates reduce risk of accumulation. - Use caution in heart failure: avoid rapid volume expansion. - Avoid rapid infusion in neonates: limit to recommended pediatric rates. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium chloride IV can interact with other agents that affect fluid and electrolyte status.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use can cause severe hypernatremia. - Potassium chloride IV: combined high chloride load may precipitate metabolic acidosis.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal loss of sodium, requiring careful monitoring. - ACE inhibitors or ARBs: may potentiate hypotension when large volumes are infused. - NSAIDs: can reduce renal perfusion, enhancing risk of fluid overload. - Corticosteroids: may alter sodium retention, necessitating electrolyte checks.